Overall Approach to the Evaluation and Treatment of Osteoporosis in Men

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-12-374602-3.00048-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteoporosis in Men: Epidemiology, Pathophysiology, and Clinical Characterization

  2013cited by this paper
• New Guidelines for the Prevention and Treatment of Osteoporosis

  2009cited by this paper
• A Comparison of Frailty Indexes for the Prediction of Falls, Disability, Fractures, and Mortality in Older Men

  2009cited by this paper
• Risk factors for low BMD in healthy men age 50 years or older: a systematic review

  2009cited by this paper
• Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians.

  2008cited by this paper
• Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men.

  2008cited by this paper
• National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist.

  2008cited by this paper
• Risk factors for low bone mass in healthy 40–60 year old women: A systematic review of the literature

  2008cited by this paper
• FRAX™ and the assessment of fracture probability in men and women from the UK

  2008cited by this paper
• Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures

  2008cited by this paper
• Physical Performance and Risk of Hip Fractures in Older Men

  2008cited by this paper
• Diagnosis and treatment of vitamin D deficiency

  2008cited by this paper
• Screening for Osteoporosis in Men: A Systematic Review for an American College of Physicians Guideline

  2008cited by this paper
• Bone turnover in elderly men: relationships to change in bone mineral density

  2007cited by this paper
• Osteoporosis in men.

  2007cited by this paper
• Vitamin D deficiency.

  2007cited by this paper
• Androgen deprivation therapy for prostate cancer: new concepts and concerns

  2007cited by this paper
• RETRACTED ARTICLE: Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis – usefulness of alendronate and risedronate

  2007cited by this paper
• Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study

  2007cited by this paper
• Effectiveness and safety of vitamin D in relation to bone health.

  2007cited by this paper
• The use of parathyroid hormone in the treatment of osteoporosis

  2007cited by this paper
• Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial.

  2007cited by this paper
• Risk of subsequent fracture after low-trauma fracture in men and women.

  2007cited by this paper
• High-trauma fractures and low bone mineral density in older women and men.

  2007cited by this paper
• Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.

  2007cited by this paper
• Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

  2006cited by this paper
• DHEA in elderly women and DHEA or testosterone in elderly men.

  2006cited by this paper
• Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.

  2006cited by this paper
• Long-term effects of calcium-vitamin-D3-fortified milk on bone geometry and strength in older men.

  2006cited by this paper
• Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

  2006cited by this paper
• Predictors of Non‐Spine Fracture in Elderly Men: The MrOS Study

  2006cited by this paper
• Testosterone and estradiol among older men.

  2006cited by this paper
• Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.

  2006cited by this paper
• BMD and Risk of Hip and Nonvertebral Fractures in Older Men:A Prospective Study and Comparison With Older Women

  2006cited by this paper
• The near absence of osteoporosis treatment in older men with fractures

  2005cited by this paper
• Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.

  2005cited by this paper
• Prevention of falls and consequent injuries in elderly people.

  2005cited by this paper
• Risk of fracture after androgen deprivation for prostate cancer.

  2005cited by this paper
• Effect of Testosterone Replacement on Trabecular Architecture in Hypogonadal Men

  2005cited by this paper
• Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

  2005cited by this paper
• The decline of androgen levels in elderly men and its clinical and therapeutic implications.

  2005cited by this paper
• The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.

  2005cited by this paper
• Identification of High‐Risk Individuals for Hip Fracture: A 14‐Year Prospective Study

  2005cited by this paper
• Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement

  2005cited by this paper
• Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.

  2005cited by this paper
• Endocrine regulation of bone turnover in men

  2005cited by this paper
• Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.

  2005cited by this paper
• Predictive Value of BMD for Hip and Other Fractures

  2005cited by this paper
• Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization.

  2004cited by this paper
• Diagnosis of Osteoporosis in Men, Premenopausal Women, and Children

  2004cited by this paper
• Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial.

  2004cited by this paper
• Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.

  2004cited by this paper
• Bone Resorption and Osteoporotic Fractures in Elderly Men: The Dubbo Osteoporosis Epidemiology Study

  2004cited by this paper
• Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.

  2004cited by this paper
• The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits.

  2004cited by this paper
• The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.

  2003cited by this paper
• Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.

  2003cited by this paper
• The Effect of Teriparatide [Human Parathyroid Hormone (1–34)] Therapy on Bone Density in Men With Osteoporosis

  2003cited by this paper
• Undertreatment of osteoporosis in men with hip fracture.

  2002cited by this paper
• BMC Musculoskeletal Disorders BioMed Central

  2002cited by this paper
• Alendronate as an effective countermeasure to disuse induced bone loss.

  2002cited by this paper
• A Randomized Trial of Nasal Spray Salmon Calcitonin in Men With Idiopathic Osteoporosis: Effects on Bone Mineral Density and Bone Markers

  2002cited by this paper
• Identifying Bone-Mass-Related Risk Factors for Fracture to Guide Bone Densitometry Measurements: A Systematic Review of the Literature

  2001cited by this paper
• Utility of heel ultrasound bone density in men.

  2001cited by this paper
• Effects of Raloxifene, a Selective Estrogen Receptor Modulator, on Bone Turnover Markers and Serum Sex Steroid and Lipid Levels in Elderly Men

  2001cited by this paper
• Does Bone Density Predict Fractures Comparably in Men and Women?

  2001cited by this paper
• Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

  2000cited by this paper
• Effects of Alendronate on Bone Density in Men with Primary and Secondary Osteoporosis

  2000cited by this paper
• Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid‐Induced Osteoporosis in Men and Women: A Randomized Trial

  2000cited by this paper
• Alendronate for the treatment of osteoporosis in men.

  2000cited by this paper
• Osteoporosis and osteoporotic fractures in men: a clinical perspective.

  2000cited by this paper
• Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium.

  1999cited by this paper
• Effect of testosterone treatment on bone mineral density in men over 65 years of age.

  1999cited by this paper
• Skeletal effects of exercise in men

  1999cited by this paper
• The 28th Amendment

  1999cited by this paper
• Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

  1998cited by this paper
• Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density.

  1997cited by this paper
• Calcium intake and the incidence of forearm and hip fractures among men.

  1997cited by this paper
• Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.

  1997cited by this paper
• Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.

  1997cited by this paper
• Current use of thiazide diuretics and prevention of femur fractures.

  1996cited by this paper
• Testosterone therapy in glucocorticoid-treated men.

  1996cited by this paper
• Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis.

  1996cited by this paper
• Vitamin D Supplementation and Fracture Incidence in Elderly Persons

  1996cited by this paper
• A multifactorial intervention to reduce the risk of falling among elderly people living in the community.

  1994cited by this paper
• Thiazides and bone mineral density in elderly men and women.

  1994cited by this paper
• Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study

  1993cited by this paper
• Calcium supplementation and increases in bone mineral density in children.

  1992cited by this paper
• Exercise and Other Factors in the Prevention of Hip Fracture: The Leisure World Study

  1991cited by this paper
• Thiazide diuretic agents and the incidence of hip fracture.

  1990cited by this paper
• Effect of thiazide on rates of bone mineral loss: a longitudinal study.

  1990cited by this paper
• Osteomalacia and osteoporosis in femoral neck fracture.

  1990cited by this paper
• The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation.

  1990cited by this paper
• Osteomalacia and femoral neck fractures in the elderly patient.

  1987cited by this paper

• More than Just Wine: The Nutritional Benefits of Grapevine Leaves

  2021cites this paper
• Nutritional valuation and food safety of endemic mediterranean halophytes species cultivated in abandoned salt pans under a natural irrigation scheme

  2021cites this paper